Related references
Note: Only part of the references are listed.Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
Jon B. Toledo et al.
BRAIN (2015)
Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
Jon B. Toledo et al.
JAMA NEUROLOGY (2015)
Age-Related Brain Expression and Regulation of the Chemokine CCL4/MIP-1 β in APP/PS1 Double-Transgenic Mice
Min Zhu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation
John S. K. Kauwe et al.
PLOS GENETICS (2014)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Quantitative Analysis of PiB-PET with FreeSurfer ROIs
Yi Su et al.
PLOS ONE (2013)
Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study
Yasuhiko Ikari et al.
ANNALS OF NUCLEAR MEDICINE (2012)
CSF Biomarker and PIB-PET-Derived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects
Michael Ewers et al.
CEREBRAL CORTEX (2012)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Chuanyu Li et al.
Current Alzheimer Research (2011)
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Saul A. Villeda et al.
NATURE (2011)
A Meta-Analysis of Cytokines in Alzheimer's Disease
Walter Swardfager et al.
BIOLOGICAL PSYCHIATRY (2010)
High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
A. Forsberg et al.
CURRENT ALZHEIMER RESEARCH (2010)
Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer's disease and mild cognitive impairment
Lars Olson et al.
EXPERIMENTAL GERONTOLOGY (2010)
Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
Nigel J. Cairns et al.
ARCHIVES OF NEUROLOGY (2009)
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease
Fei Song et al.
BRAIN RESEARCH REVIEWS (2009)
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Philine Schneider et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients
Cristian L. Achim et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Relationship of Cerebrospinal Fluid Markers to C-11-PiB and F-18-FDDNP Binding
Nelleke Tolboom et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology
Chulhee Choi et al.
JOURNAL OF CLINICAL NEUROLOGY (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Intrathecal inflammation precedes development of Alzheimer's disease
E Tarkowski et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation
C Ito et al.
BONE MARROW TRANSPLANTATION (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients
D Galimbert et al.
ANNALS OF NEUROLOGY (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Share Paper
